Angiosarcoma Metastatic clinical trials

Explore recruiting angiosarcoma metastatic clinical trials.

Recruiting angiosarcoma metastatic studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Angiosarcoma Metastatic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase III study comparing Trabectedin (T) versus T plus tTF-NGR to entrap T inside the tumor in patients with metastatic and/or refractory soft tissue sarcoma (STS), Acronym: TRABTRAP

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Angiosarcoma Metastatic trials by city

Angiosarcoma Metastatic in Toronto Angiosarcoma Metastatic in Vancouver Angiosarcoma Metastatic in Montreal Angiosarcoma Metastatic in Calgary Angiosarcoma Metastatic in Edmonton Angiosarcoma Metastatic in Ottawa Angiosarcoma Metastatic in Winnipeg Angiosarcoma Metastatic in Quebec City Angiosarcoma Metastatic in Hamilton Angiosarcoma Metastatic in Kitchener Angiosarcoma Metastatic in London Angiosarcoma Metastatic in Halifax Angiosarcoma Metastatic in New York Angiosarcoma Metastatic in Los Angeles Angiosarcoma Metastatic in Chicago Angiosarcoma Metastatic in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease